![]() |
|
|
Molecular Pharmacology, Vol 16, 77-90, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201
[3H]Dihydroergocryptine binds to membrane sites on guinea-pig vas deferens, which have
the characteristics expected of
-adrenoreceptors. Specific binding is rapid, reversible and
saturable, with a maximal occupancy of 190 fmol [3H]dihydroergocryptine bound/mg
protein. Saturable binding occurs to a single population of high affinity sites (KD = 1.55
nM) with no evidence for cooperative interactions. [3H]Dihydroergocryptine binding is
markedly pH and temperature sensitive. While Na+ and K+ do not affect binding, maximal
[3H]dihydroergocryptine binding observed in the presence of Mg2+ is antagonized by
increasing concentrations of Ca2+.
-Adrenoreceptor agonists and antagonists of several
classes inhibit binding to vas deferens membranes. Catecholamines show marked stereo-specificity in relation to inhibition of binding of [3H]dihydroergocryptine. The potency
for displacement of [3H]dihydroergocryptine by phenylethylamine agonists is identical to
their agonistic potency in eliciting contractile responses of the isolated guinea-pig vas
deferens. Some discrepancies between binding and physiological affinities of imidazoline
-adrenoreceptor ligands were observed and discussed. There is close agreement between
dissociation constants of azapetine and dihydroergocryptine, as estimated from radioligand binding and antagonism of physiological responses. As no other biogenic amine
receptors binds [3H]dihydroergocryptine, there is no interference in using this radioligand
to study
-adrenoreceptor mechanisms in guinea-pig vas deferens.